AANEM Practice News Express

AANEM News Express

Meaningful Use Hardship Applications Streamlined

    1/27/2016
CMS is implementing changes due to the recent passage of The Patient Access and Medicare Protection Act (PAMPA),  moving more quickly on applications for exceptions from Meaningful Use Stage 2 requirements for the 2015 calendar year.

Do EMG Results Predict Response to Epidural Steroid Injections?

    1/27/2016
This study in the Journal of Nature and Science evaluated the relationship between EMG diagnosis and pain improvement following epidural steroid injection

Fludarabine may be considered in the treatment of refractory CIDP - new evidence from a small case series

    1/13/2016
New evidence from a small case series in Journal of Clinical Neuromuscular Disease - Fludarabine has shown efficacy in the treatment of CIDP associated with monoclonal gammopathy and distal acquired demyelinating symmetric neuropathy, and may be an option for patients with refractory disease

ABEM MOCP Annual Recording Fees Due by Dec. 31

    12/29/2015
If you are enrolled in the American Board of Electrodiagnostic Medicine’s (ABEM) Maintenance of Certification Program (MOCP), your deadline for submitting your annual CME recording fee ($30) and form is December 31 to avoid a late fee.

Meaningful Use Exemption Update

    12/29/2015
Congress passed legislation allowing CMS to move more quickly on applications for exemptions from Meaningful Use Stage 2 requirements for the 2015 calendar year. Physicians will have until March 15, 2016, to apply for an exemption from the 2015 meaningful use program year.

Baseline QST Predicts Development of Neuropathy in Patients Treated with Oxaliplatin

    12/16/2015
This study in Clinical Colorectal Cancer provides important information about the value of comprehensive quantitative sensory testing (QST) that incorporates thermal threshold detection measures in the evaluation and prediction of severity of neuropathy in patients receiving or about to receive treatment with oxaliplatin.

Correcting Neuromuscular Deficits with Gene Therapy in Pompe disease

    12/1/2015
This  study in Annals of Neurology supports further exploration of AAV-based gene therapy in the treatment of Pompe Disease.

2016 Fee Schedule—What Does This Mean for Reimbursement?

    12/1/2015
On On October 30, 2015, the Center for Medicare and Medicaid Services (CMS) released the Final Rule for the 2016 Medicare Physician Payment Schedule. Within this document and addendum are updates to the relative value units (RVU), which include work RVUs, practice expense (PE) RVUs, malpractice (MP) RVUs, as well as the proposed Medicare conversion factor.

2016 Medicare Physician Fee Schedule

    11/18/2015
On October 30, 2016, the Center for Medicare and Medicaid Services (CMS) released the Final Rule for the 2016 Medicare Physician Payment Schedule. Following is a summary of some of the changes that could affect AANEM members for the calendar year (CY) 2016.

Lumbar Intradiscal Platelet Rich Plasma (PRP) Injections: A Prospective, Double-blind, Randomized Controlled Study

    11/18/2015
This double-blind, randomized controlled study in PM&R shows promising early results for platelet rich plasma (PRP) injections for chronic lower back pain.


First
Prev
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
...
Next
Last

Advertisement

ABEM

Advertisement

TPP

Advertisement

Devon products